Finally, CBE delivery into SCD and β-thalassemic HSPCs resulted in efficient (86.3–93.3%) editing of the GATA1 BS in the BCL11A enhancer (Figure 1). This evidence concerns the gene BCL11A and Schnyder corneal dystrophy.